AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Fair Disclosure Wire)
CORPORATE PARTICIPANTS . Michael Goldberg, Emisphere Technologies, CEO . Russell Hull, University of Calgary, Scientific Advisor OVERVIEW The company presented data at the meeting of the American Society of Hematology. Although the study did not meet initial end points, it did show that oral Heparin was effectively equivalent to injectable LOVENOX, marking the first time an oral macromolecule was safely delivered. Consequently, a product can now be developed with a partner to compete in the marketplace. Question/answer session focused on partnership opportunities and product marketing. PRESENTATION SUMMARY S1. Results Overview (MG) 1. ...